Lingerfelt & Davis Announce 152,491 SF Lease at Carmel Church Business Center

Lingerfelt and The Davis Companies (Davis) are pleased to announce the recent signing of a 152,491 square foot lease with M.C. Dean at Carmel Church Business Center, located at 11174 Enterprise Parkway, Ruther Glen, VA 22546. Jake Servinsky and Jimmy Appich of JLL represented M.C. Dean and Graham Stoneburner and Mark Douglas of Cushman & […]

Sealed Air Reports Q2 2025 Results

Second Quarter 2025 Highlights and Financial Results — Kristen Actis-Grande joining Sealed Air as Chief Financial Officer — Protective volumes further stabilized in the quarter with the industrial portfolio inflecting to volume growth driven by our continued transformation efforts — Food sales flat with favorable price offset by softer volume driven by market pressure in

Expanse Announces $18M Inaugural Fund Alongside Investments in Hamsa, OneHealthGroup, and Zocks

Expanse's Venture Arm Launches with a Diverse Portfolio of Businesses on the Forefront of Enabling Technologies Powering the Future of Finance, Healthcare and Commerce Expanse, an asset management firm built with a family office perspective, is announcing their $18M Inaugural Fund alongside investments in a diverse portfolio of businesses on the forefront of enabling technologies

Axcelis Announces Financial Results for Second Quarter 2025

Q2 Highlights: — Revenue of $194.5 million — GAAP Gross Margin of 44.9%, and Non-GAAP Gross Margin of 45.2% — GAAP Operating Margin of 14.9% and Non-GAAP Operating Margin of 17.7% — GAAP Diluted earnings per share of $0.98, and Non-GAAP Diluted earnings per share of $1.13 Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial

Karyopharm to Report Second Quarter 2025 Financial Results on August 11, 2025

Conference Call Scheduled for Monday, August 11, 2025, at 8:00 a.m. ET — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it will report second quarter 2025 financial results on Monday, August 11, 2025. Karyopharm's management team will host a conference call and audio webcast at 8:00 a.m.

Perspecta Unveils New Website to Showcase Bold Vision for the Future of Provider Data

Precision Data. Powerful Perspectives. Proven Success. Perspecta, a leading provider of healthcare navigation and provider data management solutions, today announced the launch of its newly redesigned corporate website. This evolution reflects Perspecta's sustained growth and unwavering commitment to data transparency, innovation, and delivering high-integrity provider information. https://mma.prnewswire.com/media/2382857/Perspecta_Logo_1.jpg “Accurate provider information is the foundation of effective

Zero Candida Technologies Announces DTC Eligibility and to Present at OTCQB Venture Virtual Investor Conference on August 7th

Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the “Company” or “ZCT”), a FemTech medical device company revolutionizing women's health, is pleased to announce that its common shares are now eligible for Depository Trust Company (“DTC”) electronic clearing and settlement services. Additionally, the Company will present live at the OTCQB Venture Virtual Investor

Mill Creek Finishes No. 4 in ORA Power Rankings for Online Reputation

Company Also Recognized for Maintenance Performance in “Best of Awards” Mill Creek Residential, a leading developer, owner-operator and investment manager specializing in premier rental housing across the U.S., today announced it is ranked No. 4 in the seventh annual ORAPower Rankingsin the Division II category. The rankings, compiled by J Turner Research, measure an apartment

GIFT PEACE OF MIND WITH A PRENUP: THE “IT” WEDDING GIFT OF 2025

TrustedPrenup.com launches “Gift a Prenup” so family members and advisors can help protect generational wealth. As wedding season heats up and the largest wealth transfer in history unfolds, prenups are emerging as the most thoughtful gift for engaged couples. TrustedPrenup.com's new “Gift a Prenup” feature lets parents, grandparents, and financial advisors give the lasting gift

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS

CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived, rhCollagen for tissue regeneration and medical aesthetics, today announced that it will report financial results for the second quarter on Wednesday, August 20, 2025, before the opening of the U.S. financial markets. https://mma.prnewswire.com/media/2217353/CollPlant_Logo.jpg About CollPlant CollPlant

Scroll to Top